|
1
|
Binder AM, LaRocca J, Lesseur C, Marsit CJ
and Michels KB: Epigenome-wide and transcriptome-wide analyses
reveal gestational diabetes is associated with alterations in the
human leukocyte antigen complex. Clin Epigenetics.
7(79)2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhu Y and Zhang C: Prevalence of
gestational diabetes and risk of progression to type 2 diabetes: A
global perspective. Curr Diab Rep. 16(7)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
International Association of Diabetes and
Pregnancy Study Groups Consensus Panel. Metzger BE, Gabbe SG,
Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod
M, et al: International association of diabetes and pregnancy study
groups recommendations on the diagnosis and classification of
hyperglycemia in pregnancy. Diabetes Care. 33:676–682.
2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sobngwi E, Boudou P, Mauvais-Jarvis F,
Leblanc H, Velho G, Vexiau P, Porcher R, Hadjadj S, Pratley R,
Tataranni PA, et al: Effect of a diabetic environment in utero on
predisposition to type 2 diabetes. Lancet. 361:1861–1865.
2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Catalano PM and Hauguel-De Mouzon S: Is it
time to revisit the Pedersen hypothesis in the face of the obesity
epidemic? Am J Obstet Gynecol. 204:479–487. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
El Hajj N, Schneider E, Lehnen H and Haaf
T: Epigenetics and life-long consequences of an adverse nutritional
and diabetic intrauterine environment. Reproduction. 148:R111–R120.
2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yan C, Chen J and Chen N: Long noncoding
RNA MALAT1 promotes hepatic steatosis and insulin resistance by
increasing nuclear SREBP-1c protein stability. Sci Rep.
6(22640)2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Leng L, Zhang C, Ren L and Li Q:
Construction of a long non-coding RNA-mediated competitive
endogenous RNA network reveals global patterns and regulatory
markers in gestational diabetes. Int J Mol Med. 43:927–935.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tuna M, Machado AS and Calin GA: Genetic
and epigenetic alterations of microRNAs and implications for human
cancers and other diseases. Genes Chromosomes Cancer. 55:193–214.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Esteves JV, Enguita FJ and Machado UF:
MicroRNAs-mediated regulation of skeletal muscle GLUT4 expression
and translocation in insulin resistance. J Diabetes Res.
2017(7267910)2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pordzik J, Jakubik D, Jarosz-Popek J,
Wicik Z, Eyileten C, De Rosa S, Indolfi C, Siller-Matula JM, Czajka
P and Postula M: Significance of circulating microRNAs in diabetes
mellitus type 2 and platelet reactivity: Bioinformatic analysis and
review. Cardiovasc Diabetol. 18(113)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Stirm L, Huypens P, Sass S, Batra R,
Fritsche L, Brucker S, Abele H, Hennige AM, Theis F, Beckers J, et
al: Maternal whole blood cell miRNA-340 is elevated in gestational
diabetes and inversely regulated by glucose and insulin. Sci Rep.
8(1366)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Method. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Iempridee T, Wiwithaphon S, Piboonprai K,
Pratedrat P, Khumkhrong P, Japrung D, Temisak S, Laiwejpithaya S,
Chaopotong P and Dharakul T: Identification of reference genes for
circulating long noncoding RNA analysis in serum of cervical cancer
patients. FEBS Open Bio. 8:1844–1854. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li C, Chen J and Qin G: Partial Youden
index and its inferences. J Biopharm Stat. 29:385–399.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361.
2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Carter G, Miladinovic B, Patel AA, Deland
L, Mastorides S and Patel NA: Circulating long noncoding RNA GAS5
levels are correlated to prevalence of type 2 diabetes mellitus.
BBA Clin. 4:102–107. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bahari G, Hashemi M, Naderi M,
Sadeghi-Bojd S and Taheri M: Long non-coding RNA PAX8-AS1
polymorphisms increase the risk of childhood acute lymphoblastic
leukemia. Biomed Rep. 8:184–190. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Han J, Zhou W, Jia M, Wen J, Jiang J, Shi
J, Zhang K, Ma H, Liu J, Ren J, et al: Expression quantitative
trait loci in long non-coding RNA PAX8-AS1 are associated with
decreased risk of cervical cancer. Mol Genet Genomics.
291:1743–1748. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang Y, Li F and Chen J: MYC promotes the
development of papillary thyroid carcinoma by inhibiting the
expression of lncRNA PAX8-AS1:28. Oncol Rep. 41:2511–2517.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Arner P and Kulyté A: MicroRNA regulatory
networks in human adipose tissue and obesity. Nat Rev Endocrinol.
11:276–288. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Miao C, Chang J, Zhang G and Fang Y:
MicroRNAs in type 1 diabetes: New research progress and potential
directions. Biochem Cell Biol. 96:498–506. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Vienberg S, Geiger J, Madsen S and
Dalgaard LT: MicroRNAs in metabolism. Acta Physiol (Oxf).
219:346–361. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Anton L, Olarerin-George AO, Hogenesch JB
and Elovitz MA: Placental expression of miR-517a/b and miR-517c
contributes to trophoblast dysfunction and preeclampsia. PLoS One.
10(e0122707)2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wander PL, Boyko EJ, Hevner K, Parikh VJ,
Tadesse MG, Sorensen TK, Williams MA and Enquobahrie DA:
Circulating early- and mid-pregnancy microRNAs and risk of
gestational diabetes. Diabetes Res Clin Pract. 132:1–9.
2017.PubMed/NCBI View Article : Google Scholar
|
